NCT06047535 2023-09-21Naxitamab and Granulocyte-Macrophage Colony Stimulating Factor (GM-CSF) Combined With Isotretinoin for Maintenance Treatment of Patients With High-Risk Neuroblastoma in First Complete Response.SciClone PharmaceuticalsPhase 4 Not yet recruiting62 enrolled